ArticleThe Lancet. Child & adolescent health2025

Late effects after high-risk neuroblastoma (LEAHRN): a multicentre, cross-sectional cohort study from the Children's Oncology Group.

Tara O Henderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.